Only 7% of consumers rate social health information as highly accurate, raising the stakes for healthcare and pharma marketing content credibility.
CSAM scanning halts as the ePrivacy Directive expires, complicating child safety as Greece and others eye youth social bans.
A new LLM powers its apps with shopping-led discovery but keeps brands dependent on Meta’s closed ecosystem.
In today’s podcast episode, we discuss the main takeaways from the recent social media harm trials, how much Americans are using social networks (and which ones they’re using the most), and the changes we expect to see as a result of this landmark verdict. Join Senior Director of Podcasts and host Marcus Johnson, along with Principal Forecasting Writer Ethan Cramer-Flood and Analyst Emmy Liederman. Listen anywhere, or watch on YouTube or Spotify.
Scheduled Trial Reels let creators time experiments globally, improving influencer campaign performance on Instagram.
It balances UGC trust with monetization, embedding brands into conversations to rival social competitors for intent-rich engagement.
No longer direct response, it now guides viewers to CTV content and fuels ad-supported tiers.
Australia's social media ban is struggling to take hold as users easily circumvent restrictions.
A TikTok-Cameo integration unlocks new revenue streams, enhancing TikTok’s value in influencer marketing strategies.
Q4 TikTok video views jumped 68% as wellness, CPG, and retail soared—proof TikTok is now a sales engine.
MPA backlash forces a rethink of borrowed ratings, exposing risks of using third-party trust markers.
Instagram Plus tools may offer extended Story life, rewatch data, and new traffic insights to boost performance.
With Meta and Google found liable for addictive designs, healthcare marketers and doctors must prepare for concerned parents seeking guidance on preventing social media addiction in their children.
Healthcare and pharma brands must adapt digital marketing for the AI search era, make CTV actionable for older viewers, and align social strategies with how consumers discover health content.
Meta's new genAI tools speed production and improve performance, but consumer trust still challenges payoff.
A verdict that their feed designs are addictive could yield warnings to users, tighter ad rules, and legal reforms.
New Snapchat ad formats and strong engagement aim to sway marketers despite a modest ad revenue share.
Meta and YouTube were ruled negligent in addiction case as the jury claimed the platforms failed to warn youth—raising legal and reputational risks for advertisers.